David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
CALL
B&G Foods
BGS
$286M
| $1.2M | ﹤0.01% |
114,000
+74,000
| +185% | +$685K |
|
|
IROHU
2877
DELISTED
Iron Horse Acquisitions Corp Unit
IROHU
| $1.2M | ﹤0.01% |
+119,035
| New | +$1.19M |
|
2878
PagerDuty
PD
$945M
| $1.19M | ﹤0.01% |
51,613
-10,461
| -17% | -$226K |
|
2879
SPS Commerce
SPSC
$2.9B
| $1.19M | ﹤0.01% |
6,163
+1,477
| +32% | +$258K |
|
2880
Agree Realty
ADC
$9.24B
| $1.19M | ﹤0.01% |
18,942
-205,918
| -92% | -$11.9M |
|
2881
Marten Transport
MRTN
$1.18B
| $1.19M | ﹤0.01% |
56,704
-80,157
| -59% | -$1.53M |
|
2882
Luxfer Holdings
LXFR
$459M
| $1.19M | ﹤0.01% |
133,034
+78,584
| +144% | +$730K |
|
2883
PUT
Perion Network
PERI
$385M
| $1.18M | ﹤0.01% |
38,300
-1,000
| -3% | -$28.4K |
|
2884
Phathom Pharmaceuticals
PHAT
$712M
| $1.18M | ﹤0.01% |
129,389
-1,175
| -0.9% | -$10.1K |
|
2885
Mitsubishi UFJ Financial
MUFG
$251B
| $1.18M | ﹤0.01% |
+137,041
| New | +$1.16M |
|
2886
iShares Russell 1000 Value ETF
IWD
$84.2B
| $1.18M | ﹤0.01% |
+7,137
| New | +$1.1M |
|
2887
Cheesecake Factory
CAKE
$5.65B
| $1.18M | ﹤0.01% |
33,678
-31,367
| -48% | -$1M |
|
2888
Fulgent Genetics
FLGT
$549M
| $1.18M | ﹤0.01% |
40,695
-2,548
| -6% | -$68.2K |
|
2889
Littelfuse
LFUS
$10.3B
| $1.18M | ﹤0.01% |
4,396
+1,329
| +43% | +$318K |
|
2890
PUT
Arbor Realty Trust
ABR
$961M
| $1.17M | ﹤0.01% |
77,300
| – | – |
|
|
AVDX
2891
DELISTED
AvidXchange
AVDX
| $1.17M | ﹤0.01% |
94,642
+2,212
| +2% | +$22.1K |
|
2892
Blue Bird Corp
BLBD
$1.86B
| $1.17M | ﹤0.01% |
43,476
-4,362
| -9% | -$89.8K |
|
2893
Brookfield Renewable
BEPC
$6.2B
| $1.17M | ﹤0.01% |
40,603
-62,493
| -61% | -$1.59M |
|
|
CVAC
2894
DELISTED
CureVac
CVAC
| $1.17M | ﹤0.01% |
+277,538
| New | +$1.51M |
|
2895
UroGen Pharma
URGN
$2.27B
| $1.17M | ﹤0.01% |
77,873
+44,240
| +132% | +$574K |
|
2896
PJT Partners
PJT
$4.46B
| $1.17M | ﹤0.01% |
11,460
+1,654
| +17% | +$142K |
|
2897
Coty
COTY
$2.35B
| $1.17M | ﹤0.01% |
93,801
-133,977
| -59% | -$1.45M |
|
|
SPWR
2898
CALL
DELISTED
SunPower Corporation Common Stock
SPWR
| $1.16M | ﹤0.01% |
+240,700
| New | +$1.15M |
|
2899
Blend Labs
BLND
$350M
| $1.16M | ﹤0.01% |
455,484
+234,321
| +106% | +$353K |
|
2900
PUT
Levi Strauss
LEVI
$8.12B
| $1.16M | ﹤0.01% |
70,000
| – | – |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.